Author:
Mirimanoff R.-O.,Zouhair A.
Reference32 articles.
1. Aparicio J, Germà JR, García del Muro X et al. (2005) Risk-adapted management for patients with clinical stage I seminoma: the Second Spanish Germ Cell Cancer Cooperative Group study. J Clin Oncol 23: 8717–23
2. Bjurlin MA, August CZ, Weldon-Linne M (2007) Histologically pure stage I seminoma with an elevated beta-hCG of 4497 UI/l. Urology 70: 1007.e13–5
3. Bompas E, Fléchon A, Biron P et al. (2002) Management of advanced seminoma: retrospective study of 96 patients. Bull Cancer 89: 877–85
4. Bruns F, Raub M, Schaefer U et al. (2005) No predictive value of beta-hCG in patients with stage I seminoma — results of a long-term follow-up study after adjuvant radiotherapy. Anticancer Res 25:1543–6
5. Butcher DN, Gregory WM, Gunter PA et al. (1985) The biological and clinical significance of HCG-containing cells in seminoma. Br J Cancer 51: 473–8